Targeting the NAT10/XIST/YAP1 Axis-Mediated Vascular Abnormalization Enhances Immune Checkpoint Blockade in Gastric Cancer
Xuetao Lei(Key Laboratory of Guangdong Province), Guoxin Li(Affiliated Hospital of Jining Medical University), Ziyi Fu, Qingbin Yang(Key Laboratory of Guangdong Province), Wenqiang Li(Beijing Aerospace General Hospital), Gengtai Ye(Southern Medical University), Yanmei Peng(Chinese Academy of Tropical Agricultural Sciences), Fengping Li(Key Laboratory of Guangdong Province), Boyang Zheng(Key Laboratory of Guangdong Province), Ruoyu Ling(Key Laboratory of Guangdong Province), Jiayong He(Key Laboratory of Guangdong Province), Guofan Zhang(Southern Medical University)
Cited by 11
Related Papers
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Massive expansion and functional divergence of innate immune genes in a protostome
|Scientific Reports|2015|331
Circular RNA circRHOBTB3 acts as a sponge for miR-654-3p inhibiting gastric cancer growth
|Journal of Experimental & Clinical Cancer Research|2020|269